A trial of optimal personalised care after treatment for gynaecological cancer (TOPCAT-G)

Not Applicable

Completed

• Conditions: Gynaecological cancer; Cancer

• Registration Number: ISRCTN45565436
• Lead Sponsor: Betsi Cadwaladr University Health Board

Brief Summary

2016 Protocol article in http://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-016-0108-5 protocol 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29324539 results (added 24/01/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-23
• Study Completion: 2016-12-31
• Last Update Posted: 7 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

1. Female patients who have completed treatment for cervical, endometrial, epithelial ovarian, or vulvar cancer within the last 3 months in BCUHB in North Wales
2. Patients who have completed treatment for fallopian tube and primary peritoneal carcinoma
3. Patients will be included if they are considered fit for taking part in the trial and able to give informed consent, as assessed by the multi disciplinary team
4. Patients may have received surgery, chemotherapy, radiotherapy or a combination of these but will not be receiving any continuing treatment that requires hospital care
5. At the time of entry, patients in the view of their treating consultant will not have a definite need for continued hospital care

Exclusion Criteria

1. Patients having had treatment for sarcoma, germ cell tumour, borderline tumours or choriocarcinoma will be excluded as these women tend to require specific and/or more intense follow up often with serial imaging or tumour markers
2. Patients requiring ongoing treatment
3. The study will not include patients who do not have capacity to give informed consent or who are deemed to be unable to take part in the trial (e.g., severe learning/mental disability, severe mental health problems)
4. Patients who are not able to understand Welsh or English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Patient recruitment rate. This will be calculated from the total number of patients invited to take part in the study and the number of patients giving written consent to participate in the study<br> 2. Patient attrition rate. This will be calculated from the number of patients who gave written consent and the number of patients who have completed any measures, regardless of their completion rate<br>